You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

EMBOLEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EMBOLEX?
  • What are the global sales for EMBOLEX?
  • What is Average Wholesale Price for EMBOLEX?
Summary for EMBOLEX
Drug patent expirations by year for EMBOLEX
Recent Clinical Trials for EMBOLEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NovartisPhase 3

See all EMBOLEX clinical trials

US Patents and Regulatory Information for EMBOLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for EMBOLEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 ⤷  Sign Up ⤷  Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 ⤷  Sign Up ⤷  Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 ⤷  Sign Up ⤷  Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for EMBOLEX

See the table below for patents covering EMBOLEX around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0028813 STABLE SOLUTIONS OF HYDROGENATED ERGOTALCALOIDS OR THEIR SALTS AND HEPARIN OR ITS SALTS,AND PROCESS FOR THEIR PREPARATIONS ⤷  Sign Up
Japan H021126 ⤷  Sign Up
Malaysia 8500165 STABLE SOLUTIONS OF HYDROGENATED ERGOTALKALOIDS ⤷  Sign Up
Germany 2945636 ⤷  Sign Up
Greece 72128 ⤷  Sign Up
Ireland 50372 STABLE SOLUTIONS OF HYDROGENATED EGOTALKALOIDS ⤷  Sign Up
Denmark 155144 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.